MRNA Moderna · $61.82 Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤 Terminal终端 ↗

All coverage所有股票 · Health Care

Moderna · Health Care

MRNA

$61.82
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.莫德纳公司是一家美国制药和生物技术公司，总部位于马萨诸塞州剑桥，专注于RNA疗法，主要是mRNA疫苗。
Speculative / unprofitable投机／未盈利 Large cap大盘 $24B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Setup almost complete — likely buy trigger in ~1–3 trading days if it closes back above its 10-day average.形态接近完成——若收盘重新站上 10 日均线，预计将在约 1–3 个交易日内出现买入触发。
Open in Terminal打开终端 ↗ All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$61.82
24.4% below 52-week high低于52周高点 24.4%
Market Cap市值
$24B
Normal volume正常成交量
Beta贝塔
1.65
Moves about 1.7x the market波动幅度约为市场的 1.7 倍
RSI (14)RSI（14）
46
Neutral zone中性区域
Next Earnings下次财报
2026-08-07 (19d)
Volatility Rank波动率分位
92th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
13.5% of float

Performance价格表现

Period周期 MRNA S&P 500vs Index对比指数
1 Week近1周 -9.4% -1.5% Lagged the index by 7.9 points落后指数 7.9 个百分点
1 Month近1月 +0.0% +0.6% In line with the index与指数基本持平
3 Months近3月 +15.1% +4.7% Beat the index by 10.4 points跑赢指数 10.4 个百分点
6 Months近6月 +47.8% +7.8% Beat the index by 40.0 points跑赢指数 40.0 个百分点
Year to date年初至今 +100.3% +9.1% Beat the index by 91.2 points跑赢指数 91.2 个百分点
1 Year近1年 +92.0% +19.4% Beat the index by 72.6 points跑赢指数 72.6 个百分点

Technicals技术面

RSI (14)RSI（14） 46 Neutral zone中性区域
vs 50-day相对50日均线 +8.3% vs 50-day avg
vs 200-day相对200日均线 +42.5% vs 200-day avg
Volatility rank波动率分位 92th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$59.89
Don't chase above不追高于
$63.36
Stop止损
$49.64
Buy soon — on confirmation即将买入 — 待确认

Earnings财务业绩

19
days until next report天后公布财报
2026-08-07

Estimates being raised — 1 analysts预期上调 — 1 位分析师

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 MRNA Sector median行业中位 Cheaper than相对便宜
P/B市净率 2.82x 3.52
59%
P/S市销率 12.53x 3.02
7%
Earnings yield盈利收益率 -11.59% 2.72
8%
FCF yield自由现金流收益率 -8.48% 3.94
4%
Shareholder yield股东收益率 0.01% 1.89
11%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$803.4M
2020
$18.5B
2021
$19.3B
2022
$6.8B
2023
$3.2B
2024
$1.9B
2025
5yr CAGR5年复合增速: 19.3%
Earnings Per Share每股收益
$-1.96
2020
$28.29
2021
$20.12
2022
$-12.33
2023
$-9.28
2024
$-7.26
2025
Free Cash Flow自由现金流
$2.0B
2020
$13.3B
2021
$4.6B
2022
-$3.8B
2023
-$4.1B
2024
-$2.1B
2025
Margins利润率
Operating margin营业利润率
-158.1%
Net margin净利率
-145.2%
FCF margin自由现金流利润率
-96.3%
-32.6%Return on Equity股本回报率
-22.9%Return on Assets资产回报率
Leverage杠杆
Current ratio流动比率3.29
Capital Allocation资本配置
Stock-based comp股权薪酬$483.0M
Share count change (1y)股数变化（1年）+2.1%
Piotroski皮奥特罗斯基 3/8 Altman Z阿尔特曼Z: safe (4.6) Watch关注

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 23% of its sector on blended multiples综合估值倍数低于行业内 23% 的公司
Beta市场敏感度
1.65×
0.21×3×
Moves about 1.7× the market波动幅度约为市场的 1.7 倍
Financial Health财务健康
3/8
Altman阿尔特曼: safe
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息

Why Is It Moving为何波动

News新闻 1 recent stories — mixed1 篇最新报道，多空参半
Sector / Theme行业/主题 Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健（等权）」主题 — 46 个主题中第 6 位
Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 MRNA took relative-strength leadershipMRNA 取得相对强弱领先

Options Positioning期权持仓

Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡

Expected daily move预期日波动
±5.55%
Expected weekly move预期周波动
±12.42%
Call wall看涨密集区
$66
Put wall看跌密集区
$55
Gamma flip伽玛翻转
$60
25d risk reversal25d风险逆转
0.3%
Skew: 偏斜：balanced

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$9.3M net (0 buyers, 4 sellers)-$9.3M 净值（0 买家，4 卖家）
Concentrated ownership集中持仓
Fund基金 Grade评级 Activity动作 % of portfolio组合占比 As of截至
Perceptive Advisors A New position新建仓 1.0% 2026-03-31
Casdin Capital B New position新建仓 0.3% 2026-03-31
Coatue Management A exitexit 0.0% 2026-03-31

Signal History信号历史

NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP. Buyers rejected the 2026-06-11 low (swing low printed) but price hasn't reclaimed its 10-day average — first box ticked, not all. Last cycle was left-translated (topped early) — a bearish structural tell买入预备。买方拒绝了 2026-06-11 的低点（摆动低点已现），但价格尚未收复 10 日均线——第一项条件达成，并非全部。 上一周期为左移结构（见顶偏早）——属于看空的结构性信号
TURN SIGNALED BOTTOMING
Jul 15, 2026
MRNA took relative-strength leadershipMRNA 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $68.28.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$68.28。
Jul 13, 2026
MRNA daily MACD crossed downMRNA 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $67.01.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$67.01。
Jul 9, 2026
BUY ZONE → NEARING A HIGH买入区 → 接近高点
TAKE PROFITS止盈
Jul 8, 2026
NEARING A HIGH → BUY ZONE接近高点 → 买入区
BUY买入
Jun 26, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 26, 2026
MRNA took relative-strength leadershipMRNA 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $67.27.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$67.27。
Jun 26, 2026
MRNA weekly MACD crossed upMRNA 周线MACD上穿
The weekly MACD histogram turned positive — the slower, less-whippy momentum read.周线MACD柱状图转正 — 更慢、更少来回的动量信号。
Jun 26, 2026
MRNA made a new 52-week highMRNA 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $67.27.价格创出52周新高 — 全市场关注的动量/趋势极值。$67.27。
Jun 26, 2026
MRNA RSI reached overboughtMRNA RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $67.27.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$67.27。
Jun 23, 2026
MRNA took relative-strength leadershipMRNA 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $61.00.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$61.00。
Jun 22, 2026
NEARING A HIGH → UPTREND接近高点 → 上涨趋势
HOLD持有

Showing last 15 of显示最近15条，共 94 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.48
Value价值
-1.4
Quality质量
+0.8
Investment资本投入
+1.3
Shareholder payout股东回报
-1.0
Low volatility低波动
-2.0
Low market beta低市场敏感度
-1.1
Earnings quality盈利质量
+0.4
Short interest空头兴趣
-1.0

Company Profile公司档案

Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.莫德纳公司是一家美国制药和生物技术公司，总部位于马萨诸塞州剑桥，专注于RNA疗法，主要是mRNA疫苗。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
  • Inventory build

Recent News最新动态

Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes GlobeNewswire Inc. 2026-07-17
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。
Open Analyzer打开分析器 Browse All Stocks浏览所有股票